DURECT Corporation (DRRX)
Sep 11, 2025 - DRRX was delisted (reason: acquired by BHC)
1.910
-0.020 (-1.04%)
Inactive · Last trade price
on Sep 10, 2025
DURECT Employees
DURECT had 21 employees as of December 31, 2024. The number of employees decreased by 37 or -63.79% compared to the previous year.
Employees
21
Change (1Y)
-37
Growth (1Y)
-63.79%
Revenue / Employee
$127,462
Profits / Employee
-$267,538
Market Cap
n/a
Employees Chart
DRRX News
- 3 months ago - Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025 - Accesswire
- 4 months ago - DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health - PRNewsWire
- 4 months ago - Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout - Benzinga
- 4 months ago - Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease - Accesswire
- 7 months ago - DURECT Corporation Reports First Quarter 2025 Financial Results and Provides Business Update - PRNewsWire
- 9 months ago - DURECT Corporation (DRRX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 9 months ago - DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - PRNewsWire
- 9 months ago - DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update - PRNewsWire